Cite
HARVARD Citation
Ikeda, S. et al. (2022). Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: A model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents – CORRIGENDUM. Psychological medicine. 52 (13), p. 2847. [Online].